Combined Therapy for Chronic HCV With Interferon-α Plus Ribavirin Improved Insulin Resistance but did not Affect the Adiponectin Levels
Journal of Experimental & Clinical Medicine · 2011
DOI: 10.1016/j.jecm.2010.12.004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Experimental & Clinical Medicine, 2011. Verfasst von Shih-Ting Tseng und 4 weiteren Autor:innen. Die Arbeit nennt 24 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Tseng, S., Chiu, W., Wang, H., Chen, K., & Peng, R. Y. (2011). Combined Therapy for Chronic HCV With Interferon-α Plus Ribavirin Improved Insulin Resistance but did not Affect the Adiponectin Levels. Journal of Experimental & Clinical Medicine. https://doi.org/10.1016/j.jecm.2010.12.004
Vancouver
Tseng S, Chiu W, Wang H, Chen K, Peng RY. Combined Therapy for Chronic HCV With Interferon-α Plus Ribavirin Improved Insulin Resistance but did not Affect the Adiponectin Levels. Journal of Experimental & Clinical Medicine. 2011. doi:10.1016/j.jecm.2010.12.004
BibTeX
@article{Tseng2011,
author = {Tseng, Shih-Ting and Chiu, Wen-Ta and Wang, Hui-Er and Chen, Kuan-Chou and Peng, Robert Y.},
title = {Combined Therapy for Chronic HCV With Interferon-α Plus Ribavirin Improved Insulin Resistance but did not Affect the Adiponectin Levels},
journal = {Journal of Experimental & Clinical Medicine},
year = {2011},
doi = {10.1016/j.jecm.2010.12.004}
}
EUVIMED